Navigation Links
Wimbledon Health Partners Expands Services to Include Needle EMG in New York
Date:1/13/2014

Boca Raton, Florida (PRWEB) January 13, 2014

Wimbledon Health Partners, a leading on-site diagnostic testing company providing physicians’ vascular, echocardiogram and NCV testing announced expanded services in New York state. As of February 1st, Wimbledon Health Partners will now be offering needle EMGs in coordination with the existing NCV testing.

Electromyography (EMG) is a diagnostic procedure conducted by a licensed physician that is used to assess the health of muscles and the nerve cells that control them. Motor neurons transmit electrical signals that cause muscles to contract. An EMG translates these signals into graphs, sounds or numerical values that a specialist interprets. An EMG uses tiny devices called electrodes to transmit or detect electrical signals. During a needle EMG, a needle electrode inserted directly into a muscle records the electrical activity in that muscle.

EMG results can reveal nerve dysfunction, muscle dysfunction or problems with nerve-to-muscle signal transmission. A doctor may order an EMG if you have signs or symptoms that may indicate a nerve or muscle disorder. Such symptoms may include:

  •     Tingling
  •     Numbness
  •     Muscle weakness
  •     Muscle pain or cramping
EMG results are often necessary to help diagnose or rule out a number of conditions such as:
  •     Muscle disorders, such as muscular dystrophy or polymyositis
  •     Diseases affecting the connection between the nerve and the muscle, such as myasthenia gravis
  •     Disorders of nerves outside the spinal cord (peripheral nerves), such as carpal tunnel syndrome or peripheral neuropathies
  •     Disorders that affect the motor neurons in the brain or spinal cord, such as amyotrophic lateral sclerosis or polio
  •     Disorders that affect the nerve root, such as a herniated disk in the spine

Wimbledon Health Partners Director of Marketing, Meredith Troy commented on the expansion of services from a marketing perspective, “Wimbledon Health Partners is moving at lightning speed to deliver on our mission to provide the most complete and comprehensive diagnostics available to physicians nationwide. EMGs are the gold standard in diagnostics and exactly the type of testing that insurance companies have been wanting for their patients. Our recent addition of needle EMGs in New York is but a first step to offering this very important diagnostic procedure in other states in the coming future.”

About Wimbledon Health Partners:

Wimbledon Health Partners has been formed in response to the demand to attain on-site diagnostic testing capabilities for circulatory conditions that can be detected through the use of vascular ultrasound. Furthering our capabilities, nerve conduction velocity testing (NCV) is also utilized to support diagnosis of nerve involvement and manage risk. Wimbledon Health Partners is an innovative cooperative marketing and practice-enhancement program that provides physicians with the educational, compliance, and marketing tools necessary to provide quality, state-of-the-art, in-office testing procedures. For more information go to dxtesting.com or 855-200-VCOA (8262).

Read the full story at http://www.prweb.com/releases/2014/01/prweb11484936.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Wimbledon Health Partners Rolls Out Two New Service Lines to Meet Diagnostic Testing Needs of Physicians Nationwide
2. Wimbledon Health Partners, the Leading On-Site Diagnostic Testing Organization, Welcomes New Corporate Leadership
3. Wimbledon Health Partners Adds 50 Physician Consultants to the Team to Meet Growing Diagnostic Testing Demand
4. HealthWright Technologies Joins Wimbledon Health Partners National Team of Outside Sales Consultants
5. You Survived Cancer: Now Pay Attention to Your Overall Health
6. NIH awards $20 million over 5 years to train next generation of global health researchers
7. Weill Cornell Medical College establishes Center for Healthcare Informatics and Policy
8. Esophageal Cancer Surgery Can Leave Lingering Health Problems, Study Says
9. Climate Change Could Be Tough on Seniors Health: Study
10. Supporting LGB children may influence their long-term health, BU study finds
11. U.S. Spends Too Little on Public Health Initiatives: Report
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2017)... ... 2017 , ... CareSet Labs released the Root NPI Graph today at the ... greatly improved version of the Doctor Referral teaming dataset commonly available from Medicare. , ... called the the “Doctor Referral Dataset” as released by Medicare and “DocGraph” as released ...
(Date:6/24/2017)... ... June 24, 2017 , ... ... at 217 Portion Road in Lake Ronkonkoma, Dental365 offers patients high-quality and affordable ... that visits to the dentist fit into their patients’ busy lifestyles. Dental365 also ...
(Date:6/23/2017)... CA (PRWEB) , ... June 23, 2017 , ... By ... earned its ninth consecutive four-star rating from premier online charity evaluator, Charity Navigator, validating ... the top 1% of all charities reviewed by Charity Navigator and earns ANRF a ...
(Date:6/23/2017)... ... June 23, 2017 , ... Military Connection friend ... entry to the JFK Virgin Atlantic lounge. , Bensko is no stranger to ... years ago, Bensko dedicated her life to supporting our wounded veterans. A world-class photographer, ...
(Date:6/23/2017)... , ... June 23, 2017 , ... ... Cancer Conference from Sept. 18 to 20. , The two-day conference is focused ... with the goal of improving patients’ lives and eliminating racial breast cancer-related disparities. ...
Breaking Medicine News(10 mins):
(Date:6/14/2017)... June 14, 2017 The Bio Supply Management ... City of Fremont and the Biomedical Manufacturing ... industry in California by providing ... networking, and fostering workforce development. The primary focus of ... of start-ups, as well as small and mid-sized biomedical ...
(Date:6/13/2017)... -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a ... Food and Drug Administration (FDA) has notified the Company that ... Zhejiang, China manufacturing facility has been ... clearance of the Warning Letter related to our ... of the progress we have made in our ongoing quality ...
(Date:6/11/2017)... , June 10, 2017  Eli Lilly and Company (NYSE: ... three Phase 3 studies of galcanezumab, an investigational treatment ... late-breaking data on several key secondary endpoints for galcanezumab ... from these studies (EVOLVE-1, EVOLVE-2 and REGAIN) will be ... scientific meeting in Boston . ...
Breaking Medicine Technology: